Projecting human pharmacokinetics of therapeutic antibodies from nonclinical data
نویسندگان
چکیده
منابع مشابه
Nonclinical safety, pharmacokinetics, and pharmacodynamics of atacicept.
Atacicept, a soluble recombinant fusion protein of the human immunoglobulin (Ig) G(1) Fc and the extracellular domain of the human transmembrane activator and calcium modulator and cyclophylin ligand interactor receptor, acts as an antagonist of both B lymphocyte stimulator and a proliferating-inducing ligand. Here we determined the nonclinical safety, pharmacokinetics and pharmacodynamics of a...
متن کاملPharmacokinetics of therapeutic monoclonal antibodies used in oncology.
This review presents the clinical pharmacokinetics of the marketed therapeutic monoclonal antibodies used in oncology. Aspects regarding absorption, tissue distribution, elimination as well as factors influencing pharmacokinetics, pharmacodynamics and kinetic interactions are also discussed.
متن کاملProjecting clinical insight from quality simulation data.
Providing care to the mechanically ventilated patient can present many challenges. Most clinicians agree that maintaining the airway is important, particularly when depending on higher mean airway pressure to maintain adequate oxygenation.1 As a result, some health-care providers may be reluctant to manipulate the endotracheal tube (ETT) in fear of compromising the airway and threatening the pa...
متن کاملNonclinical analysis of the safety, pharmacodynamics, and pharmacokinetics of plasma‐derived human FXIII concentrate in animals
Factor XIII (FXIII) is a coagulation protein which plays a major role in hemostasis by covalently cross-linking fibrin molecules, thereby stabilizing the blood clot and increasing resistance to fibrinolysis. FXIII deficiency, either congenital or acquired, is associated with spontaneous bleeding, increased bleeding time, and poor wound healing. Purified plasma-derived human FXIII concentrate (p...
متن کاملPharmacokinetics of Monoclonal Antibodies
Monoclonal antibodies (mAbs) have developed in the last two decades into the backbone of pharmacotherapeutic interventions in a variety of indications, with currently more than 40 mAbs approved by the US Food and Drug Administration, and several dozens more in clinical development. This tutorial will review major drug disposition processes relevant for mAbs, and will highlight product-specific ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: mAbs
سال: 2011
ISSN: 1942-0862,1942-0870
DOI: 10.4161/mabs.3.1.13799